Accupril (quinapril recalls
The FDA has published 3 recalls involving Accupril (quinapril since 2022. The latest was reported on 25 May 2022. Most were for nitrosamine impurity. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2022
Last 12 months0reported
Class I00% of total
Ongoing0latest 25 May 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 3 100%Class III 0 0%
Why accupril (quinapril is recalled
Companies
By year
All accupril (quinapril recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Accupril (Quinapril HCl Tablets) 40 mg recalled by Pfizer | Pfizer | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Accupril (Quinapril HCl Tablets) 20 mg recalled by Pfizer | Pfizer | Nitrosamine Impurity | Nationwide |
| Drug | CLASS II | Accupril (Quinapril HCl Tablets) 10 mg recalled by Pfizer | Pfizer | Nitrosamine Impurity | Nationwide |
Should you stop taking Accupril (quinapril?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.